These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12968213)

  • 21. Attention deficit/hyperactivity disorder: a review and update.
    Cormier E
    J Pediatr Nurs; 2008 Oct; 23(5):345-57. PubMed ID: 18804015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
    Kollins SH
    J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Fowler JS; Ding YS
    Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
    Harpin VA
    Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.
    Sagvolden T; Sergeant JA
    Behav Brain Res; 1998 Jul; 94(1):1-10. PubMed ID: 9708834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.
    Rostain AL
    Postgrad Med; 2008 Sep; 120(3):27-38. PubMed ID: 18824823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical review: evidence-based diagnosis and treatment of ADHD in children.
    Nair J; Ehimare U; Beitman BD; Nair SS; Lavin A
    Mo Med; 2006; 103(6):617-21. PubMed ID: 17256270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R; Mulas F; Forssberg H
    Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
    Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
    Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
    Ramos-Quiroga JA; Bosch-Munsó R; Castells-Cervelló X; Nogueira-Morais M; García-Gimenez E; Casas-Brugué M
    Rev Neurol; 2006 May 16-31; 42(10):600-6. PubMed ID: 16703528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P; Sever J; Zalsman G; Weizman A
    Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement.
    Putukian M; Kreher JB; Coppel DB; Glazer JL; McKeag DB; White RD
    Clin J Sport Med; 2011 Sep; 21(5):392-401. PubMed ID: 21892014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.
    Connor DF
    J Dev Behav Pediatr; 2002 Feb; 23(1 Suppl):S1-9. PubMed ID: 11875284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.